Pharmacist Medication Insights: Hizentra for Primary Immunodeficiency
November 17th 2021Hizentra is indicated for the treatment of primary immunodeficiency in adults and pediatric patients 2 years of age and older and maintenance therapy in adults with chronic inflammatory demyelinating polyneuropathy.
Expert: Legalization of Psychedelic Drugs Would ‘Broaden Access to Research’
November 10th 2021Ismail Lourido Ali, the director and counsel of policy and advocacy at the Multidisciplinary Association for Psychedelic Studies (MAPS), addresses the difference between legalization and decriminalization of psychedelic drugs, specifically in reference to the impact on medical research.
Sequencing Liver-directed Therapy With Systemic Therapy When Treating Gastrointestinal NETs
November 10th 2021Gaby Gabriel, MD, program director, interventional radiology residency and assistant program director, diagnostic radiology residency, University of Kentucky, discusses the potential sequencing in the combination of liver-directed therapy with systemic therapy.
How Systemic Therapy Differs From Liver-directed Therapy When Treating Patients With NETs
November 9th 2021Gaby Gabriel, MD, program director, interventional radiology residency and assistant program director, diagnostic radiology residency, University of Kentucky, discussed how systemic therapy differs from liver-directed therapy.
Rate of Treatment-Related Mortality, Most Common Causes in the Treatment of Burkitt Lymphoma
November 9th 2021Adam Olszewski, MD, associate professor of medicine in Alpert Medical School at Brown University, discusses the rate of treatment-related mortality and the most common causes in the treatment of Burkitt lymphoma.
How Pharmacists Can Support the Intervention, Prevention of Chronic Kidney Disease
November 8th 2021Peter Stenvinkel, MD, PhD, FASN, full professor and senior lecturer at Karolinska University Hospital, Karolinska Institutet, discusses what pharmacists can do to support patients in the intervention or prevention of chronic kidney disease.
The Role of Nrf2, Vitamin K in DNA Damage Signaling, Senescence, Inflammaging
November 8th 2021Peter Stenvinkel, MD, PhD, FASN, full professor and senior lecturer at Karolinska University Hospital, Karolinska Institutet, discusses the role of Nrf2 and vitamin K in DNA damage signaling, senescence, and inflammaging.
Assessing the Link Between Senescence, Early Vascular Aging in Patients With Chronic Kidney Disease
November 8th 2021Peter Stenvinkel, MD, PhD, FASN, full professor and senior lecturer at Karolinska University Hospital, Karolinska Institutet, discusses the link between senescence and early vascular aging in the context of chronic kidney disease.
How to Counteract the Contributing Factors to Early Vascular Aging
November 8th 2021Peter Stenvinkel, MD, PhD, FASN, full professor and senior lecturer at Karolinska University Hospital, Karolinska Institutet, discusses what may be some of the contributing factors to early vascular aging and how might they be counteracted.
How Health Systems Can Address the National Blood Shortage, Increase Blood Donations
November 8th 2021Jennifer Andrews, MD, pediatric hematologist-oncologist at Vanderbilt University Medical Center and medical director of Vanderbilt University Medical Center’s blood bank, discusses what health systems can do to address the national blood shortage and increase blood donations.
How Specialty Pharmacies Can Support Palliative Care During Cancer Treatment
November 8th 2021Jameshia Below, PharmD, an assistant professor of pharmacy practice at the University of Louisiana Monroe College of Pharmacy, explains how palliative care can support the cancer treatment process, and how specialty pharmacies can support this type of care.
Identifying, Developing Novel, Effective Therapies for Vascular Calcification, Early Vascular Aging
November 8th 2021Peter Stenvinkel, MD, PhD, FASN, full professor and senior lecturer at Karolinska University Hospital, Karolinska Institutet, discusses the next steps to identify and develop novel and effective therapeutic targets for vascular calcification and early vascular aging.
Expert: MDMA Is Very Likely to Be FDA-Approved for PTSD by the End of 2023
November 8th 2021Kelan Thomas, PharmD, MS, associate professor of clinical sciences at Touro University California College of Pharmacy, discusses common themes or key points being raised in the field of psychedelic medicine at recent conferences.
Assessing the Efficacy of Novel Treatments for Vascular Calcification in Patients With CKD
November 8th 2021Peter Stenvinkel, MD, PhD, FASN, full professor and senior lecturer at Karolinska University Hospital, Karolinska Institutet, discusses the therapeutic strategies or treatments for vascular calcification that have been found to be effective in patients with chronic kidney disease.
Current Clinical Therapeutic Strategies, Novel Treatments for Vascular Calcification
November 7th 2021Peter Stenvinkel, MD, PhD, FASN, full professor and senior lecturer at Karolinska University Hospital, Karolinska Institutet, discusses what the current clinical therapeutic strategies and novel treatments are for vascular calcification.